James F Powers Selected Research

James F Powers Research Topics

Disease

21	Pheochromocytoma 01/2020 - 07/2002
17	Neoplasms (Cancer) 01/2020 - 07/2005
6	Paraganglioma (Paragangliomas) 01/2020 - 04/2013
4	Hypoxia (Hypoxemia) 01/2018 - 10/2002
4	Neoplasm Metastasis (Metastasis) 01/2014 - 04/2008
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2008 - 07/2002
2	Neurofibromatoses (Neurofibromatosis) 10/2002 - 07/2002
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2018
1	Primary Hyperparathyroidism 11/2017
1	Disease Progression 01/2013
1	Carcinogenesis 01/2013
1	Brain Death (Brain Dead) 06/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2008
1	Giant Cell Arteritis (Horton Disease) 02/2005
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2005
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2005
1	Neuroblastoma 01/2005
1	Hyperplasia 01/2003

Drug/Important Bio-Agent (IBA)

6	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2020 - 07/2005
5	Proteins (Proteins, Gene)FDA Link 09/2008 - 01/2003
4	EnzymesIBA 01/2020 - 07/2002
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018 - 10/2002
4	CatecholaminesIBA 01/2008 - 07/2002
2	Oxygen (Dioxygen)IBA 11/2018 - 01/2018
2	LuciferasesIBA 01/2014 - 03/2012
2	Proto-Oncogene Proteins c-retIBA 01/2008 - 07/2002
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 02/2005 - 07/2002
1	4-carboxyphenylglyoxalIBA 01/2020
1	PolyaminesIBA 01/2020
1	CD163 antigenIBA 06/2019
1	ProteomeIBA 06/2019
1	AntioxidantsIBA 11/2018
1	EnkephalinsIBA 01/2018
1	Parathyroid Hormone (Parathormone)IBA 11/2017
1	Myc associated factor XIBA 11/2017
1	A-Form DNA (A-DNA)IBA 01/2014
1	Azacitidine (5 Azacytidine)FDA Link 01/2014
1	CamptothecinIBA 01/2014
1	Topoisomerase I InhibitorsIBA 01/2014
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 02/2013
1	TOR Serine-Threonine KinasesIBA 02/2013
1	Adenosine Triphosphate (ATP)IBA 02/2013
1	Mechanistic Target of Rapamycin Complex 2IBA 02/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2012
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 02/2012
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2012
1	Dihydroxyphenylalanine (Dopa)IBA 02/2012
1	Perilipin-1IBA 09/2008
1	Periodic AcidIBA 09/2008
1	LipidsIBA 09/2008
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2008
1	Phenylethanolamine N-MethyltransferaseIBA 01/2008
1	Growth Factor ReceptorsIBA 08/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2007
1	Cyclin D1IBA 08/2007
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 08/2007
1	Contrast MediaIBA 11/2006
1	Oxidoreductases (Dehydrogenase)IBA 07/2005
1	Staphylococcal Protein A (Protein A)IBA 07/2005
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	Leukemia Inhibitory FactorIBA 02/2005
1	Nicotine FDA Link 01/2005
1	Calcium Channels (Calcium Channel)IBA 10/2004
1	Messenger RNA (mRNA)IBA 01/2003
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 10/2002
1	Hypoxia-Inducible Factor 1IBA 10/2002
1	Transcription Factors (Transcription Factor)IBA 10/2002
1	U 0126 (UO 126)IBA 10/2002
1	Nerve Growth Factor (NGF)IBA 10/2002
1	LigandsIBA 07/2002

Therapy/Procedure

3	Therapeutics 04/2013 - 11/2006
1	Drug Therapy (Chemotherapy) 01/2014
1	Nephrectomy 06/2010
1	Intravenous Injections 04/2008